Europe
RefluxStop™ is CE marked in Europe. It is currently available in:
- Germany
- United Kingdom
- Switzerland
- Spain
- Italy
- France
- Austria
- Sweden
- Norway
The share
Implantica AG is a public company listed on Nasdaq First North Premier Growth Market through Swedish Depositary Receipts (SDRs) since 21 September 2020. One SDR represents one underlying Class A share in the Company. The Company has two share classes, Class A and Class B shares.
| Ticker: | IMP A SDB |
|---|---|
| ISIN code: | SE0014855029 |
Largest shareholders
As of June 30, 2025
| Name | Holding of capital |
|---|---|
| Peter Forsell | 46.6% |
| Handelsbanken Fonder | 8.8% |
| EFG Bank | 6.9% |
| UBS | 3.7% |
| Avanza Pension | 2.8% |
| UBP | 2.8% |
| SEB Life | 2.7% |
| SIX SIS AG | 1.6% |
| Nordea Liv | 1.4% |
| Stephan Siegenthaler | 1.3% |
| LGT Bank | 1.1% |
| Backahill Utveckling | 1.1% |
| Fjärde AP-Fonden | 1.1% |
| IF | 1.0% |
| Nordnet Pensionsförsäkring AB | 0.9% |
| Largest shareholders | 83.75% |
| Other shareholders | 16.25% |